In its latest dive into healthcare, Amazon is launching a generic medication subscription service through its online pharmacy.
RxPass, which will be available to Prime members, will deliver generic drugs for common conditions like high blood pressure, anxiety and acid reflux. The tech and retail giant said the service will cost a flat fee of $5 per month.
The program won't accept insurance, and...
Digital health tech company Huma acquired clinical trial data specialist Alcedis, expanding the British company's capabilities in the digital clinical trial space.
Huma will create an advanced clinical trials division utilizing German-based Alcedis' platform that will offer digital health solutions spanning various stages of the development process, from early stage development to phase 4...
Mark Cuban Cost Plus Drug Company (MCCPDC) announced a partnership with pharmacy benefit manager RxPreferred Benefits.
The companies said the deal will allow employers and their members using RxPreferred access to MCCPDC medications through their plan.
MCCPDC is a public-benefit corporation and online pharmacy that aims to provide medications at a lower cost by working directly with distributors...
Editor's note: This article has been updated with additional context from Heal.
Heal, a home-based primary care and telehealth company, is planning layoffs ahead of a potential sale.
According to WARN notices, Heal would cut 182 jobs in Los Angeles County and 60 positions in New York City. A company spokesperson told MobiHealthNews the company is in active discussions with possible buyers, and...
Dozee scores 510(k) for AI contactless sensor for RPM
Indian medical device company Dozee has received the United States Food and Drug Administration's 510(k) clearance for its proprietary contactless sensor for remote patient monitoring.
The Dozee sensor sheet, which is placed under a hospital bed mattress, captures micro-vibrations from patients using Ballistocardiography. These vibrations are...
Pharma company Boehringer Ingelheim and Click Therapeutics announced an expanded partnership to develop and commercialize another prescription digital therapeutic for patients with schizophrenia.
The deal will net Click up to $460 million, plus tiered royalties. It builds on an earlier collaboration announced in 2020 that developed CT-155, an initial therapeutic for schizophrenia.
The companies...
Anumana, a joint venture between EHR data company nference and the Mayo Clinic, entered into a multiyear partnership with Pfizer to develop an AI-based tool for the early detection of cardiac amyloidosis.
Under the agreement, Anumana will research and pursue FDA De Novo classification for an algorithm that could find signals within electrocardiograms (ECGs) that hint at the condition. The...
Mark Cuban Cost Plus Drug Company (MCCPDC) announced a partnership with pharmacy benefit manager EmsanaRx to allow employers and employees access to lower-cost prescription drugs via a new platform called EmsanaRx Plus.
EmsanaRx Plus is a supplemental discount drug platform designed specifically for employers. It utilizes EmsanaRx's ability to integrate with employer-sponsored drug benefits, and...
Lokavant, which provides a data analytics platform for clinical trials, raised $21 million in a funding round led by Edison Partners.
Roivant Sciences, which builds health tech and biotech companies called "Vants," participated in the raise. Lokavant was incubated at Roivant and piloted its platform with some of the company's other biotech ventures.
As part of the fundraise, Gregg Michaelson,...
Canadian health tech company PointClickCare announced a strategic collaboration with Pfizer to share its real-world data on seniors.
The cloud-based software company focused on elder care covers the long-term and post-acute care market. PointClickCare will provide Pfizer with real-world data insights that specifically represent older adults, especially those in long-term care facilities, to help...
_1.jpg?itok=wDEAkDAi "A woman holding a smartphone looking out a window.")
